{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:37:52Z","timestamp":1792085872431,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.jaad.2013.10.049","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T01:00:41Z","timestamp":1389229241000},"page":"489-498.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"title":["A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia"],"prefix":"10.1016","volume":"70","author":[{"given":"Walter","family":"Gubelin Harcha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Barboza Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsen-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensei","family":"Katsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine","family":"Ferron-Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dushen","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.10.049_bib1","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/j.1524-4725.1998.tb00009.x","article-title":"Prevalence of male pattern hair loss in 18-49 year old men","volume":"24","author":"Rhodes","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.10.049_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.1365-2133.2001.04289.x","article-title":"The prevalence and types of androgenetic alopecia in Korean men and women","volume":"145","author":"Paik","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2133.2010.09640.x","article-title":"Prevalence of androgenetic alopecia in China: a community-based study in six cities","volume":"162","author":"Wang","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib4","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/archderm.143.11.1401","article-title":"Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey","volume":"143","author":"Su","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib5","first-page":"804","article-title":"A random study of Asian male androgenetic alopecia in Bangkok, Thailand","volume":"28","author":"Pathomvanich","year":"2002","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2013.10.049_bib6","first-page":"202","article-title":"A community study of male androgenetic alopecia in Bishan, Singapore","volume":"41","author":"Tang","year":"2000","journal-title":"Singapore Med J"},{"key":"10.1016\/j.jaad.2013.10.049_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.47102\/annals-acadmedsg.V31N6p751","article-title":"A retrospective study on the characteristics of androgenetic alopecia among Asian races in the National Skin Center, a tertiary dermatological referral center in Singapore","volume":"31","author":"Goh","year":"2002","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaad.2013.10.049_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/0190-9622(92)70134-2","article-title":"The psychological effects of androgenetic alopecia in men","volume":"26","author":"Cash","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.5021\/ad.2012.24.3.311","article-title":"Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study","volume":"24","author":"Han","year":"2012","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/0974-7753.77510","article-title":"Androgenetic alopecia: quality-of-life and associated lifestyle patterns","volume":"2","author":"Sawant","year":"2010","journal-title":"Int J Trichology"},{"key":"10.1016\/j.jaad.2013.10.049_bib11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.4065\/80.10.1316","article-title":"Psychological effect, pathophysiology, and management of androgenetic alopecia in men","volume":"80","author":"Stough","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2013.10.049_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1346-8138.2011.01378.x","article-title":"Evaluation of efficacy and safety of finasteride 1 mg in 3177 Japanese men with androgenetic alopecia","volume":"39","author":"Sato","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib13","first-page":"247","article-title":"Finasteride in the treatment of Japanese men with male pattern hair loss","volume":"14","author":"Kawashima","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib14","first-page":"379","article-title":"Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study","volume":"18","author":"Lin","year":"2002","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jaad.2013.10.049_bib15","first-page":"38","article-title":"Long-term (5-year) multinational experience with finasteride 1 mg in the treatment of men with androgenetic alopecia","volume":"12","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib16","first-page":"1","article-title":"Promising therapies for treating and\/or preventing androgenic alopecia","volume":"17","author":"McElwee","year":"2012","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.jaad.2013.10.049_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000246242","article-title":"The 5 alpha-reductase system and its inhibitors: recent development and its perspective in treating androgen-dependent skin disorders","volume":"193","author":"Chen","year":"1996","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.10.049_bib18","series-title":"Hair growth and disorders","first-page":"159","article-title":"Male androgenetic alopecia","author":"Messenger","year":"2008"},{"key":"10.1016\/j.jaad.2013.10.049_bib19","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0733-8635(05)70396-X","article-title":"Androgen metabolism as it affects hair growth in androgenetic alopecia","volume":"14","author":"Kaufman","year":"1996","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2013.10.049_bib20","series-title":"Disorders of hair growth: diagnosis and treatment","first-page":"257","article-title":"Androgenetic alopecia","author":"Olsen","year":"1994"},{"key":"10.1016\/j.jaad.2013.10.049_bib21","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/pros.21318","article-title":"5Alpha-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression","volume":"71","author":"Godoy","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.jaad.2013.10.049_bib22","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1046\/j.1365-2133.1998.02504.x","article-title":"Predominance of type I 5alpha-reductase in apocrine sweat glands of patients with excessive or abnormal odor derived from apocrine sweat (osmidrosis)","volume":"139","author":"Sato","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib23","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/1523-1747.ep12317162","article-title":"Activity of the type 1 5 alpha-reductase exhibits regional differences in isolated sebaceous glands and whole skin","volume":"105","author":"Thiboutot","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib24","first-page":"252","article-title":"Efficacy, safety, and tolerability of dutasteride 0.5 mg once\u00a0daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study","volume":"63","author":"Eun","year":"2010","journal-title":"J\u00a0Am\u00a0Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib25","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jaad.2006.05.007","article-title":"The importance of dual 5alpha-reductase inhibition in\u00a0the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride","volume":"55","author":"Olsen","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.10.049_bib26","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00007611-197511000-00009","article-title":"Male pattern baldness: classification and incidence","volume":"68","author":"Norwood","year":"1975","journal-title":"South Med J"},{"key":"10.1016\/j.jaad.2013.10.049_bib27","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0733-8635(05)70397-1","article-title":"Photographic documentation of hair growth in androgenetic alopecia","volume":"14","author":"Canfield","year":"1996","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2013.10.049_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003495-199957010-00014","article-title":"Finasteride: a review of its use in male pattern hair loss","volume":"57","author":"McClellan","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.jaad.2013.10.049_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.eururo.2004.05.008","article-title":"Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia","volume":"46","author":"Debruyne","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.jaad.2013.10.049_bib30","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJMoa0908127","article-title":"Effect of dutasteride on\u00a0the risk of prostate cancer","volume":"362","author":"Andriole","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.10.049_bib31","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.5489\/cuaj.477","article-title":"The effect of dutasteride on the detection of prostate cancer: a set of meta-analyses","volume":"7","author":"Monga","year":"2013","journal-title":"Can Urol Assoc J"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213011717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213011717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:30:19Z","timestamp":1759271419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213011717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0190962213011717"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.10.049","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718235830.793492226","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718235830.793491169","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.10.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}